Skip to main content

Table 1 Baseline characteristics of antiretroviral therapy naïve 147 HIV-infected children

From: Association of APOBEC3G genotypes and CD4 decline in Thai and Cambodian HIV-infected children with moderate immune deficiency

Characteristics1

Total (n=147)

APOBEC3G subtype AA (n=127)

APOBEC3G subtype AG (n=17)

APOBEC3G subtype GG(n=3)

P value

Age (years)

6.5 (4.3-8.8)

6.7 (4.3-8.8)

6.3 (4.2-7.9)

2.8 (1.2-10.1)

0.55

% male

35%

35%

35%

33%

0.99

% CDC clinical classification N:A:B

1:63:36%

1:67:32%

6:35:59%

0:33:67%

0.05

Weight (kg)

17 (13.5-21.5)

17 (14–21.5)

16 (13.5-21)

11.5 (8.6-21)

0.39

Height (cm)

108 (95–121)

110 (95–121)

103 (99–115)

86 (70–120)

0.39

Weight for age z-score

−1.32 (−2.03 to −0.79)

−1.27 (−2.02 to −0.77)

−1.33 (−2.03 to −0.89)

−1.66 (−2.11 to −1.32)

0.72

Height for age z-score

−1.66 (−2.5 to −0.93)

−1.66 (−2.48 to −0.97)

−1.39 (−2.33 to −0.87)

−2.72 (−3.01 to −1.83)

0.30

Weight for height z-score

−0.43 (−1.22 to 0.09)

−0.44 (−1.22 to 0.12)

−0.54 (−1.11 to −0.27)

0.03 (−0.4 to 0.37)

0.32

Baseline CD4%

20 (17–23)

20 (17–23)

19 (17–26.5)

22 (17–23)

0.81

Baseline CD4 count (cells/mm3)

605 (460–846)

601 (449–846)

620 (551–836)

1333 (675–2195)

0.09

Baseline HIV-RNA (log10copies/mL)

4.7 (4.3-5.0)

4.6 (4.3-5)

4.9 (4.4-5)

5 (3.9-5.5)

0.43

  1. 1Data are presented as median (IQR).
  2. APOBEC3G genotypes AA (186H/H), AG (186H/R), GG (186R/R).